StockData
RedHill Biopharma Ltd. logo

RedHill Biopharma Ltd. (RDHL) stock

RDHLNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 27, 2026Score 0/30
$0.38−0.01 (-1.60%)

Close on Nov 13, 2026Market cap $1.91MP/E –Yield –

RedHill Biopharma cash

Cash and short-term investments held at the end of each period.

RedHill Biopharma's cash was $5.16M at Jun 30, 2026. For fiscal 2025 it was $3.97M, down 14.0% from the year before. Over ten years it grew -15.5% a year on average. The highest annual figure on record is $53.79M in fiscal 2016.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.97M-14.0%
FY2024Dec 31, 2024$4.62M-17.1%
FY2023Dec 31, 2023$5.57M-72.1%
FY2022Dec 31, 2022$19.97M-32.3%
FY2021Dec 31, 2021$29.47M+0.6%
FY2020Dec 31, 2020$29.30M+0.9%
FY2019Dec 31, 2019$29.02M+0.1%
FY2018Dec 31, 2018$29.01M+76.3%
FY2017Dec 31, 2017$16.46M-69.4%
FY2016Dec 31, 2016$53.79M+150.0%
FY2015Dec 31, 2015$21.52M+265.2%
FY2014Dec 31, 2014$5.89M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.16M-29.1%
Q4 FY2025Dec 31, 2025$3.97M-28.7%
Q2 FY2025Jun 30, 2025$2.87M-59.0%
Q4 FY2024Dec 31, 2024$4.62M-76.9%
Q2 FY2024Jun 30, 2024$7.28M-73.0%
Q4 FY2023Dec 31, 2023$5.57M-80.7%
Q2 FY2023Jun 30, 2023$7.00M-76.3%
Q4 FY2022Dec 31, 2022$19.97M-61.5%
Q2 FY2022Jun 30, 2022$26.99M-64.5%
Q1 FY2022Mar 31, 2022$28.85M-1.5%
Q4 FY2021Dec 31, 2021$29.47M+32.3%
Q2 FY2021Jun 30, 2021$51.82M-36.5%
Q1 FY2021Mar 31, 2021$75.97M+161.8%
Q4 FY2020Dec 31, 2020$29.30M+225.7%
Q2 FY2020Jun 30, 2020$22.27M-3.2%
Q1 FY2020Mar 31, 2020$81.61M+181.4%
Q4 FY2019Dec 31, 2019$29.02M+421.6%
Q2 FY2019Jun 30, 2019$9.00M+19.0%
Q1 FY2019Mar 31, 2019$23.01M+39.9%
Q4 FY2018Dec 31, 2018$29.01M+89.3%
Q2 FY2018Jun 30, 2018$5.56M-81.2%
Q1 FY2018Mar 31, 2018$7.56M-85.9%
Q4 FY2017Dec 31, 2017$16.46M-23.5%
Q2 FY2017Jun 30, 2017$15.32M+160.0%
Q1 FY2017Mar 31, 2017$29.62M–
Q4 FY2016Dec 31, 2016$53.79M–
Q4 FY2015Dec 31, 2015$21.52M–
Q4 FY2014Dec 31, 2014$5.89M–

More RedHill Biopharma figures

See a number that looks wrong?